Skip to main content
SpringerLink
Log in

Incremental “Therapeutic” Myocardial Exposure to Catecholamines: Incidence and Impact in Takotsubo Syndrome

  • Original Article
  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

Abstract

Background

Although Takotsubo syndrome (TS) was once considered to be rare and largely benign, it is now recognized to represent a major cause of cardiac morbidity and mortality, especially in ageing women. The biochemical precipitant of attacks of TS is an increase in catecholamine concentrations within the myocardium, engendering inflammatory activation via biased post-receptor signalling at myocardial β2-adrenoceptor level. Cases of TS have been reported in patients treated with catecholamines, and with antidepressants which limit catecholamine re-uptake. In the current investigation, we sought to delineate the extent and potential impact of this “iatrogenic” form of TS.

Methods/Results

Patients’ data from a regional registry of 301 consecutive cases of TS were evaluated after exclusion of patients (n = 20) in whom TS had occurred in association with life threatening extracardiac disease states. A total of 55 (18%) of patients were identified as having antecedent exposure to potentially “iatrogenic” agents (tricyclic antidepressants in 24 cases, β2-adrenoceptor agonists in 15). Demographics, including proportion of male patients, did not differ significantly between patients with and without “iatrogenic” TS, but plasma concentrations of the catecholamine metabolite normetanephrine tended to be greater (median 1149 pmol/L vs 938 pmol/L; p = 0.03). Long-term survival (median follow-up 3 years) was marginally (p = 0.13) worse for patients with “iatrogenic” TS.

Conclusion

Potentially iatrogenic precipitation of TS attacks (via iatrogenic elevation of catecholamine levels and β2-adrenoceptor stimulation) is common, associated with greater elevation of plasma normetanephrine concentrations, and also with a trend towards increased long-term mortality when compared to the remainder of TS patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Medina de Chazal H, Del Buono MG, Keyser-Marcus L, Ma L, Moeller FG, Berrocal D, et al. Stress Cardiomyopathy Diagnosis and Treatment. Journal of the American College of Cardiology. 2018;72(16):1955.

  2. Akashi YJ, Goldstein DS, Barbaro G, Ueyama T. Takotsubo cardiomyopathy: a new form of acute, reversible heart failure. Circulation. 2008;118(25):2754–62.

    Article  Google Scholar 

  3. Shin S-N, Yun KH, Ko JS, Rhee SJ, Yoo NJ, Kim NH, et al. Left ventricular Thrombus associated with Takotsubo cardiomyopathy: a Cardioembolic cause of cerebral infarction. Journal of Cardiovascular Ultrasound. 2011;19(3):152–5.

    Article  Google Scholar 

  4. Izumo M, Nalawadi S, Shiota M, Das J, Dohad S, Kuwahara E, et al. Mechanisms of acute mitral regurgitation in patients with takotsubo cardiomyopathy: an echocardiographic study. Circ Cardiovasc Imaging. 2011;4(4):392–8.

    Article  Google Scholar 

  5. Syed FF, Asirvatham SJ, Francis J. Arrhythmia occurrence with takotsubo cardiomyopathy: a literature review. Europace. 2011;13(6):780–8.

    Article  Google Scholar 

  6. Singh K, Neil CJ, Nguyen T, Stansborough J, Chong CR, Dawson D, et al. Dissociation of Early Shock in Takotsubo Cardiomyopathy from either Right or Left Ventricular Systolic Dysfunction. Heart Lung Circ. 2014;23(12):1141–8.

  7. Neil CJ, Nguyen TH, Singh K, Raman B, Stansborough J, Dawson D, et al. Relation of delayed recovery of myocardial function after Takotsubo cardiomyopathy to subsequent quality of life. Am J Cardiol. 2015;115(8):1085–9.

    Article  Google Scholar 

  8. Dawson DK, Neil CJ, Henning A, Cameron D, Jagpal B, Bruce M, et al. Tako-Tsubo cardiomyopathy: a heart stressed out of energy? JACC Cardiovasc Imaging. 2015;8(8):985–7.

    Article  Google Scholar 

  9. Redfors B, Vedad R, Angeras O, Ramunddal T, Petursson P, Haraldsson I, et al. Mortality in takotsubo syndrome is similar to mortality in myocardial infarction - A report from the SWEDEHEART registry. Int J Cardiol. 2015;185:282–9.

  10. Templin C, Ghadri JR, Diekmann J, Napp LC, Bataiosu DR, Jaguszewski M, et al. Clinical features and outcomes of Takotsubo (stress) cardiomyopathy. N Engl J Med. 2015;373(10):929–38.

    Article  CAS  Google Scholar 

  11. Paur H, Wright PT, Sikkel MB, Tranter MH, Mansfield C, O'Gara P, et al. High levels of circulating epinephrine trigger apical cardiodepression in a beta2-adrenergic receptor/Gi-dependent manner: a new model of Takotsubo cardiomyopathy. Circulation. 2012;126(6):697–706.

    Article  CAS  Google Scholar 

  12. Wittstein  IS, Thiemann  DR, Lima  JAC, Baughman  KL, Schulman  SP, Gerstenblith  G, et al. Neurohumoral Features of Myocardial Stunning Due to Sudden Emotional Stress. New England Journal of Medicine. 2005;352(6):539–48.

  13. Arias AM, Oberti PF, Pizarro R, Falconi ML, de Arenaza DP, Zeffiro S, et al. Dobutamine-Precipitated Takotsubo Cardiomyopathy Mimicking Acute Myocardial Infarction. Circulation. 2011;124(12):e312.

  14. Khwaja YH, Tai JM. Takotsubo cardiomyopathy with use of salbutamol nebulisation and aminophylline infusion in a patient with acute asthma exacerbation. BMJ Case Rep. 2016;2016.

  15. Vasudev R, Rampal U, Patel H, Patel K, Bikkina M, Shamoon F. Selective serotonin-norepinephrine reuptake inhibitors-induced Takotsubo cardiomyopathy. N Am J Med Sci. 2016;8(7):312–5.

    Article  Google Scholar 

  16. Neil CJ, Chong CR, Nguyen TH, Horowitz JD. Occurrence of Tako-Tsubo cardiomyopathy in association with ingestion of serotonin/noradrenaline reuptake inhibitors. Heart, lung & circulation. 2012;21(4):203–5.

  17. Kido K, Guglin M. Drug-induced Takotsubo cardiomyopathy. J Cardiovasc Pharmacol Ther. 2017;22(6):552–63.

    Article  CAS  Google Scholar 

  18. Dias A, Franco E, Figueredo VM, Hebert K, Quevedo HC. Occurrence of Takotsubo cardiomyopathy and use of antidepressants. Int J Cardiol. 2014;174(2):433–6.

    Article  Google Scholar 

  19. Wischnewsky MB, Candreva A, Bacchi B, Cammann VL, Kato K, Szawan KA, et al. Prediction of short- and long-term mortality in takotsubo syndrome: the InterTAK Prognostic Score. European journal of heart failure. 2019;N/A(N/A).

  20. Kohan AA, Levy Yeyati E, de Stefano L, Dragonetti L, Pietrani M, Perez de Arenaza D, et al. Usefulness of MRI in takotsubo cardiomyopathy: a review of the literature. Cardiovascular Diagnosis and Therapy. 2014;4(2):138–46.

    PubMed  PubMed Central  Google Scholar 

  21. Y-Hassan S. Plasma epinephrine levels and its causal link to takotsubo syndrome revisited: critical review with a diverse conclusion. Cardiovascular Revascularization Medicine. 2018.

  22. Wilson HM, Cheyne L, Brown PAJ, Kerr K, Hannah A, Srinivasan J, et al. Characterization of the Myocardial Inflammatory Response in Acute Stress-Induced (Takotsubo) Cardiomyopathy. JACC Basic Transl Sci. 2018;3(6):766–78.

  23. Nguyen TH, Neil CJ, Sverdlov AL, Mahadavan G, Chirkov YY, Kucia AM, et al. N-terminal pro-brain natriuretic protein levels in Takotsubo cardiomyopathy. Am J Cardiol. 2011;108(9):1316–21.

    Article  CAS  Google Scholar 

  24. Scally C, Rudd A, Mezincescu A, Wilson H, Srivanasan J, Horgan G, et al. Persistent long-term structural, functional, and metabolic changes after stress-induced (Takotsubo) cardiomyopathy. Circulation. 2018;137(10):1039–48.

    Article  Google Scholar 

  25. Surikow SY, Raman B, Licari J, Singh K, Nguyen TH, Horowitz JD. Evidence of nitrosative stress within hearts of patients dying of Tako-tsubo cardiomyopathy. Int J Cardiol. 2015;189:112–4.

    Article  CAS  Google Scholar 

  26. Surikow SY, Nguyen TH, Stafford I, Chapman M, Chacko S, Singh K, et al. Nitrosative stress as a modulator of inflammatory change in a model of Takotsubo syndrome. JACC: Basic to Translational Science. 2018;3(2):213–26.

    PubMed  Google Scholar 

  27. Ghadri JR, Kato K, Cammann VL, Gili S, Jurisic S, di Vece D, et al. Long-term prognosis of patients with Takotsubo syndrome. J Am Coll Cardiol. 2018;72(8):874–82.

    Article  Google Scholar 

  28. Nguyen TH, S.S., Ong GJ, Surikow S, Horowitz JD. Implications of “Secondary” Takotsubo Syndrome on Short and Long-term Event Rates [abstract]. in American Heart Association (AHA) Scientific Sessions 2017. 2017. Anaheim, California: Circulation.

  29. Zhu W, Petrashevskaya N, Ren S, Zhao A, Chakir K, Gao E, et al. Gi-biased β2AR signaling links GRK2 upregulation to heart failure. Circ Res. 2012;110(2):265–74.

  30. Lange P, Çolak Y, Ingebrigtsen TS, Vestbo J, Marott JL. Long-term prognosis of asthma, chronic obstructive pulmonary disease, and asthma-chronic obstructive pulmonary disease overlap in the Copenhagen City Heart study: a prospective population-based analysis. The Lancet Respiratory Medicine. 4(6):454–62.

  31. Wulsin LR, Vaillant GE, Wells VE. A systematic review of the mortality of depression. Psychosom Med. 1999;61(1):6–17.

    Article  CAS  Google Scholar 

  32. Campbell KA, Joseph SP, Whiting MJ, Doogue MP. The half-lives of plasma free metanephrines. Clin Endocrinol. 2012;76(5):764–6.

    Article  CAS  Google Scholar 

  33. Schwarz K, Ahearn T, Srinivasan J, Neil CJ, Scally C, Rudd A, et al. Alterations in Cardiac Deformation, Timing of Contraction and Relaxation, and Early Myocardial Fibrosis Accompany the Apparent Recovery of Acute Stress-Induced (Takotsubo) Cardiomyopathy: An End to the Concept of Transience. Journal of the American Society of Echocardiography. 2017;30(8):745–55.

  34. Singh K, Carson K, Shah R, Sawhney G, Singh B, Parsaik A, et al. Meta-Analysis of Clinical Correlates of Acute Mortality in Takotsubo Cardiomyopathy. The American journal of cardiology. 2014;113(8):1420–8.

  35. Neil C, Nguyen T, Kucia A, Crouch B, Sverdlov A, Chirkov Y, et al. Slowly resolving global myocardial inflammation/oedema in Tako-Tsubo cardiomyopathy: evidence from T2-weighted cardiac MRI. Heart (British Cardiac Society). 2012;98(17):1278–84.

Download references

Acknowledgements

We would like to acknowledge help provided by the medical staff, nursing staff and echocardiogram technicians at the Queen Elizabeth Hospital, Lyell McEwin Hospital and Royal Adelaide Hospitals.

Funding

GJ Ong was supported by a PhD scholarship through the University of Adelaide.

Author information

Authors and Affiliations

  1. Cardiology Unit, Queen Elizabeth Hospital, 28 Woodville Road, Woodville South, SA, 5011, Australia

    Gao Jing Ong, Thanh Ha Nguyen, Jeanette Stansborough, Sven Y Surikow & John D Horowitz

  2. University of Adelaide, Basil Hetzel Institute, Woodville, SA, Australia

    Gao Jing Ong, Thanh Ha Nguyen, Sven Y Surikow & John D Horowitz

Authors
  1. Gao Jing Ong
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Thanh Ha Nguyen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jeanette Stansborough
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sven Y Surikow
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. John D Horowitz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to John D Horowitz.

Ethics declarations

Conflict of Interest

The authors have no conflicts of interest to declare.

Ethical Approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee (HREC 2009094) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ong, G.J., Nguyen, T.H., Stansborough, J. et al. Incremental “Therapeutic” Myocardial Exposure to Catecholamines: Incidence and Impact in Takotsubo Syndrome. Cardiovasc Drugs Ther 34, 95–100 (2020). https://doi.org/10.1007/s10557-019-06918-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10557-019-06918-5

Keywords

Search

Navigation